The latest price target for Sanofi (NASDAQ:SNY) was reported by Argus Research on July 26, 2024. The analyst firm set a price target for $60.00 expecting SNY to rise to within 12 months (a possible 25.76% upside). 2 analyst firms have reported ratings in the last year.

The latest analyst rating for Sanofi (NASDAQ:SNY) was provided by Argus Research, and Sanofi maintained their buy rating.

The last upgrade for Sanofi SA happened on August 12, 2022 when Deutsche Bank raised their price target to N/A. Deutsche Bank previously had a sell for Sanofi SA.

There is no last downgrade for Sanofi.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sanofi, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sanofi was filed on July 26, 2024 so you should expect the next rating to be made available sometime around July 26, 2025.

While ratings are subjective and will change, the latest Sanofi (SNY) rating was a maintained with a price target of $55.00 to $60.00. The current price Sanofi (SNY) is trading at is $47.71, which is out of the analyst’s predicted range.